London Healthcare Week: A discussion on treating neurodegenerative diseases with the CEO of AC Immune
Andrea Pfeifer describes the rationale for treating neurodegenerative disease with immunotherapies, and the importance of treating people at high risk early. She covers pipeline assets in areas such as Alzheimer's and Parkinson's. Plus, why developing good diagnostics is equally as important.